Our results suggest that NRG1-ErbB4 signaling may play an important role in symptomatic epilepsy and that NRG1-ErbB4 signaling may act as a homeostasis modulator that protects the brain from aggravated epileptiform activity. Here, ERBB4 is linked to epilepsy.